Valerio Therapeutics Société anonyme (ALVIO.PA) Stock Price
€0.066 3.1%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
2 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Valerio Therapeutics Société anonyme, AI stock picks, stock alerts and much more.
ALVIO.PA AI Stock Analysis
AI stock analysis for ALVIO.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Valerio Therapeutics Société anonyme (ALVIO.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Valerio Therapeutics Société anonyme (ALVIO.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Valerio Therapeutics Société anonyme (ALVIO.PA), currently trading at €0.066, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ALVIO.PA
-
Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide.
-
Symbol
ALVIO.PA
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
10.2M
Similar Stocks
 |
Valneva SE VLA.PA |
€2.73 0.1% |
4 |
 |
Financière de Tubize SA TUB.BR |
€129.2 0.6% |
6 |
 |
OSE Immunotherapeutics SA OSE.PA |
€5.19 2% |
5 |
 |
UCB SA UCB.BR |
€163.7 0.7% |
7 |
 |
Innate Pharma S.A. IPH.PA |
€1.72 2.1% |
3 |
News
No news articles.
ALVIO.PA Alternative Data
Web Traffic
Valerio Therapeutics Société anonyme receives an estimated 516 monthly visitors to valeriotx.com, which is down by -39.4% over the last month.
-
Web Traffic
516
-
Change from Previous Month
39.4%
-
3 Month Change
54.8%
-
YoY Change
54.8%
Twitter Followers
Valerio Therapeutics Société anonyme has 5 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
5
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
Valerio Therapeutics Société anonyme currenly has an estimated 1 open job postings.
-
Job Postings
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Valerio Therapeutics Société anonyme has 53 employees.
-
LinkedIn Employees
53
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1.9%
News Mentions
Valerio Therapeutics Société anonyme was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Valerio Therapeutics Société anonyme has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
ALVIO.PA Financials
ALVIO.PA Key Metrics
-
Total Revenue
€44.5K
-
Net Income
-€5.5M
-
Earnings per Share
-€0.0334
-
Free cash flow
-€3.4M
-
EBITDA
-€4.7M
-
EBITDA Ratio
-105.921
-
Total Assets
€29.3M
ALVIO.PA 2-year Revenue & Income
ALVIO.PA 2-year Free Cash Flow
ALVIO.PA Technicals
ALVIO.PA SMA
ALVIO.PA RSI
FAQ
What's the current price of Valerio Therapeutics Société anonyme (ALVIO.PA) Stock?
The price of an Valerio Therapeutics Société anonyme (ALVIO.PA) share is €0.066.
What's the market cap of Valerio Therapeutics Société anonyme?
The current market cap of Valerio Therapeutics Société anonyme is 10.2M.
Should I buy or sell ALVIO.PA?
Valerio Therapeutics Société anonyme exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Valerio Therapeutics Société anonyme a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Valerio Therapeutics Société anonyme stock. There are several bearish signals and market challenges that could negatively impact Valerio Therapeutics Société anonyme's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Valerio Therapeutics Société anonyme (ALVIO.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Valerio Therapeutics Société anonyme stock right now, as the outlook appears bearish.
What are some stocks similar to Valerio Therapeutics Société anonyme (ALVIO.PA) that investors often compare it to?
Valerio Therapeutics Société anonyme (ALVIO.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for Valerio Therapeutics Société anonyme's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Valerio Therapeutics Société anonyme's stock price to be around €0.062 in 2026. Starting from the current price of €0.066, this represents a 6.1% change in price, indicating a bearish outlook for the stock.
How to buy Valerio Therapeutics Société anonyme (ALVIO.PA) Stock?
Valerio Therapeutics Société anonyme stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Valerio Therapeutics Société anonyme shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.